Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nabaltec AG is a German specialty chemicals company that develops and produces high-quality functional fillers and specialty alumina for various industrial and pharmaceutical applications. In the healthcare sector, the company provides high-purity aluminum hydroxide and magnesium hydroxide used as active pharmaceutical ingredients (APIs) in antacids and as excipients or adjuvants in vaccines. Nabaltec's products are characterized by high chemical purity and controlled particle size distributions, meeting international pharmacopoeia standards such as USP and EP. The company operates globally, serving the pharmaceutical, plastics, and ceramics industries from its headquarters in Schwandorf. Nabaltec is a market leader in eco-friendly flame retardants and continues to expand its presence in the life sciences market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nabaltec.